Arm 2B: TRACT/MONO CNI for kidney failure, chronic

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 13 Aug 2024: Trial registered, NCT06552169
  2. 13 Jun 2025: Trial started, NCT06552169

The trials

NCT06552169: REgulatory T Cell Therapy to Achieve Immunosuppression REduction

State
Under way
Phase
Phase 2
People
34 planned
Started
13 Jun 2025
Primary completion
Dec 2027
Arms
Arm 2B: TRACT/MONO CNI
Results
None posted
  1. 13 Aug 2024: Trial registered
  2. 13 Jun 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.